logo

Passion for Innovation. Compassion for Patients.™

Daiichi Sankyo Europe GmbH

European News

Expert report highlights urgent action needed to lessen the future impact of Atrial Fibrillation in Europe

Lixiana® (edoxaban) Approved in Switzerland